Analystreport

Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Compass Point. They set a "buy" rating and a $45.00 price target on the stock.

Voyager Therapeutics, Inc.  (VYGR) 
Last voyager therapeutics, inc. earnings: 3/3 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.voyagertherapeutics.com